Novo Holdings Io Biotech, Inc. Transaction History
Novo Holdings
- $1.15 Billion
- Q2 2025
A detailed history of Novo Holdings transactions in Io Biotech, Inc. stock. As of the latest transaction made, Novo Holdings holds 3,354,449 shares of IOBT stock, worth $3.12 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
3,354,449
Previous 3,354,449
-0.0%
Holding current value
$3.12 Million
Previous $3.66 Million
27.52%
% of portfolio
0.41%
Previous 0.33%
Shares
5 transactions
Others Institutions Holding IOBT
# of Institutions
27Shares Held
18.2MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA6.17MShares$5.74 Million1.82% of portfolio
-
Marshall Wace, LLP London, X02.11MShares$1.96 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA1.97MShares$1.83 Million0.26% of portfolio
-
Bank Of America Corp Charlotte, NC1.62MShares$1.5 Million0.0% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA864KShares$803,7031.13% of portfolio
About IO Biotech, Inc.
- Ticker IOBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,815,300
- Market Cap $26.8M
- Description
- IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...